Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-06-26 @ 10:33 AM
Study NCT ID:
NCT04442269
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2020-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Allergic Bronchopulmonary Aspergillosis | View |
Keywords: